Foresee Pharmaceuticals Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 37.49 million compared to TWD 206.67 million a year ago. Net loss was TWD 281.94 million compared to net income of TWD 21.8 million a year ago. Basic loss per share from continuing operations was TWD 2.37 compared to basic earnings per share from continuing operations of TWD 0.18 a year ago. Diluted loss per share from continuing operations was TWD 2.37 compared to diluted earnings per share from continuing operations of TWD 0.18 a year ago.
For the six months, sales was TWD 65.89 million compared to TWD 273.65 million a year ago. Net loss was TWD 461.19 million compared to TWD 100.5 million a year ago. Basic loss per share from continuing operations was TWD 3.89 compared to TWD 0.85 a year ago. Diluted loss per share from continuing operations was TWD 3.89 compared to TWD 0.85 a year ago.